Original Research

Published on 08 Feb 2024

Identification of C-PLAN index as a novel prognostic predictor for advanced lung cancer patients receiving immune checkpoint inhibitors

in Cancer Immunity and Immunotherapy

Jiaxin Wang
Huaijuan Guo
Jingjing Yang
Jingxian Mao
Ying Wang
Xuebing Yan
Hong Guo

Frontiers in Oncology

doi 10.3389/fonc.2024.1339729

1,292 views
1 citation

Review

Published on 07 Feb 2024

Modern cancer therapy: cryoablation meets immune checkpoint blockade

in Cancer Immunity and Immunotherapy

Qi Liu
Chunyang Zhang
Xuxin Chen
Zhihai Han

Frontiers in Oncology

doi 10.3389/fonc.2024.1323070

2,295 views

Original Research

Published on 05 Feb 2024

Construction and validation of a RARRES3-based prognostic signature related to the specific immune microenvironment of pancreatic cancer

in Cancer Immunity and Immunotherapy

Yimeng Sun
Xiaoyan Wang
Lin Yao
Rong He
Changfeng Man
Yu Fan

Frontiers in Oncology

doi 10.3389/fonc.2024.1246308

1,739 views
2 citations

Case Report

Published on 31 Jan 2024

Case report: A lung squamous cell carcinoma patient with a rare EGFR G719X mutation and high PD-L1 expression showed a good response to anti-PD1 therapy

in Cancer Immunity and Immunotherapy

Zhen-feng Zhu
Xu-xia Bao
Hong-yan Shi
Xi-xi Gu

Frontiers in Oncology

doi 10.3389/fonc.2024.1283008

1,743 views

Review

Published on 24 Jan 2024

Unveiling diagnostic and therapeutic strategies for cervical cancer: biomarker discovery through proteomics approaches and exploring the role of cervical cancer stem cells

in Cancer Immunity and Immunotherapy

Ameneh Jafari
Masoumeh Farahani
Meghdad Abdollahpour-Alitappeh
Asma Manzari-Tavakoli
Mohsen Yazdani
Mostafa Rezaei-Tavirani

Frontiers in Oncology

doi 10.3389/fonc.2023.1277772

2,990 views
2 citations

Original Research

Published on 18 Jan 2024

Cost-effectiveness analysis of toripalimab for metastatic or recurrent triple-negative breast cancer

in Cancer Immunity and Immunotherapy

Jiangbo Shao
Cuiping Zhan
Chunxiang Jin
Ying Jin

Frontiers in Oncology

doi 10.3389/fonc.2023.1268584

1,809 views

Original Research

Published on 15 Jan 2024

Clear cell renal cell carcinoma: immunological significance of alternative splicing signatures

in Cancer Immunity and Immunotherapy

Jiayu Zhang
Hongyi Jiang
Dapang Rao
Xishi Jin

Frontiers in Oncology

doi 10.3389/fonc.2023.1206882

1,153 views
1 citation

Original Research

Published on 09 Jan 2024

Evaluating the predictive significance of systemic immune-inflammatory index and tumor markers in lung cancer patients with bone metastases

in Cancer Immunity and Immunotherapy

Jinxian He
Gaofeng Liang
Hongyan Yu
Chengbin Lin
Weiyu Shen

Frontiers in Oncology

doi 10.3389/fonc.2023.1338809

1,525 views
2 citations

Perspective

Published on 08 Jan 2024

Preclinical and clinical studies of a tumor targeting IL-12 immunocytokine

in Cancer Immunity and Immunotherapy

Christine M. Minnar
Grace Lui
James L. Gulley
Jeffrey Schlom
Sofia R. Gameiro

Frontiers in Oncology

doi 10.3389/fonc.2023.1321318

4,231 views
5 citations

Review

Published on 04 Jan 2024

Adverse events of immune checkpoint therapy alone versus when combined with vascular endothelial growth factor inhibitors: a pooled meta-analysis of 1735 patients

in Cancer Immunity and Immunotherapy

Iuliia Kovalenko
Wern Lynn Ng
Yimin Geng
Yinghong Wang
Pavlos Msaouel
Shailender Bhatia
Petros Grivas
Raed Benkhadra
Omar Alhalabi

Frontiers in Oncology

doi 10.3389/fonc.2023.1238517

2,242 views

Original Research

Published on 03 Jan 2024

T-cell receptor determinants of response to chemoradiation in locally-advanced HPV16-driven malignancies

in Cancer Immunity and Immunotherapy

Pablo Nenclares
Adrian Larkeryd
Floriana Manodoro
Jen Y. Lee
Susan Lalondrelle
Duncan C. Gilbert
Marco Punta
Ben O’Leary
Antonio Rullan
Anguraj Sadanandam

Frontiers in Oncology

doi 10.3389/fonc.2023.1296948

2,037 views
2 citations

Original Research

Published on 22 Dec 2023

Evaluation of the efficacy and surgical-related safety of neoadjuvant immunochemotherapy in advanced resectable none small cell lung cancer (NSCLC)

in Cancer Immunity and Immunotherapy

Qin Wang
Chen Qi
Jing Luo
Nan Xu
Mao-tian Xu
Yong Qiang
Chi Zhang
Yi Shen

Frontiers in Oncology

doi 10.3389/fonc.2023.1239451

2,273 views
2 citations

Review

Published on 22 Dec 2023

Mechanism of action and therapeutic targeting of CD30 molecule in lymphomas

in Cancer Immunity and Immunotherapy

Zhaoxia Li
Wei Guo
Ou Bai

Frontiers in Oncology

doi 10.3389/fonc.2023.1301437

3,184 views
3 citations

Original Research

Published on 21 Dec 2023

Sequential PET/CT and pathological biomarker crosstalk predict response to PD-1 blockers alone or combined with sunitinib in propensity score-matched cohorts of cancer of unknown primary treatment

in Cancer Immunity and Immunotherapy

Youlong Wang
Qi Huang
Guanqing Zhong
Jun Lv
Qinzhi Guo
Yifei Ma
Xinjia Wang
Jiling Zeng

Frontiers in Oncology

doi 10.3389/fonc.2023.1191611

1,665 views

Original Research

Published on 21 Dec 2023

Utilization of cancer immunotherapy in sub-Saharan Africa

in Cancer Immunity and Immunotherapy

Elizabeth Olatunji
Saloni Patel
Katy Graef
Adedayo Joseph
Nwamaka Lasebikan
Abba Mallum
Chinelo Chigbo
Elizabeth Jaffee
Wil Ngwa

Frontiers in Oncology

doi 10.3389/fonc.2023.1266514

2,357 views
2 citations

Original Research

Published on 21 Dec 2023

Exploration of cancer associated fibroblasts phenotypes in the tumor microenvironment of classical and pleomorphic Invasive Lobular Carcinoma

in Cancer Immunity and Immunotherapy

Harsh Batra
Qingqing Ding
Renganayaki Pandurengan
Heladio Ibarguen
Neus Bota Rabassedas
Aysegul Sahin
Ignacio Wistuba
Edwin Roger Parra
Maria Gabriela Raso

Frontiers in Oncology

doi 10.3389/fonc.2023.1281650

1,985 views
1 citation

Navigation group

Articles

Identification of C-PLAN index as a novel prognostic predictor for advanced lung cancer patients receiving immune checkpoint inhibitors

Modern cancer therapy: cryoablation meets immune checkpoint blockade

Construction and validation of a RARRES3-based prognostic signature related to the specific immune microenvironment of pancreatic cancer

Case report: A lung squamous cell carcinoma patient with a rare EGFR G719X mutation and high PD-L1 expression showed a good response to anti-PD1 therapy

Unveiling diagnostic and therapeutic strategies for cervical cancer: biomarker discovery through proteomics approaches and exploring the role of cervical cancer stem cells

Cost-effectiveness analysis of toripalimab for metastatic or recurrent triple-negative breast cancer

Clear cell renal cell carcinoma: immunological significance of alternative splicing signatures

Evaluating the predictive significance of systemic immune-inflammatory index and tumor markers in lung cancer patients with bone metastases

Preclinical and clinical studies of a tumor targeting IL-12 immunocytokine

Adverse events of immune checkpoint therapy alone versus when combined with vascular endothelial growth factor inhibitors: a pooled meta-analysis of 1735 patients

T-cell receptor determinants of response to chemoradiation in locally-advanced HPV16-driven malignancies

Evaluation of the efficacy and surgical-related safety of neoadjuvant immunochemotherapy in advanced resectable none small cell lung cancer (NSCLC)

Mechanism of action and therapeutic targeting of CD30 molecule in lymphomas

Sequential PET/CT and pathological biomarker crosstalk predict response to PD-1 blockers alone or combined with sunitinib in propensity score-matched cohorts of cancer of unknown primary treatment

Utilization of cancer immunotherapy in sub-Saharan Africa

Exploration of cancer associated fibroblasts phenotypes in the tumor microenvironment of classical and pleomorphic Invasive Lobular Carcinoma